News
A study of human tumor cells implanted in mice from the MacPherson Lab at Fred Hutch describes a new way to screen for the ...
The University of Bayreuth's Biomaterials research group has, for the first time, successfully applied the CRISPR-Cas9 ...
“We have demonstrated, for the first time worldwide, that CRISPR-Cas9 can be used to incorporate a desired sequence into ...
The flexibility of CRISPR/Cas9 editing is severely constrained by the requirement that the modification site is located in close proximity to the landing sequences. Here, authors develop a ...
CRISPR Therapeutics has exciting gene-editing candidates in the works. Iovance Biotherapeutics (NASDAQ: IOVA) and CRISPR Therapeutics (NASDAQ: CRSP) are two incredibly innovative biotechs ...
Tesla sure has a thing for random-seeming codenames for its models. The Model 3 sedan revised last year, for example, carried the internal designation "Highland." For the 3's SUV sibling ...
Furthermore, organoids were subjected to in vitro differentiation and genome editing using CRISPR/Cas9 technology ... highlighting the potential of organoids to model pathophysiology. Intestinal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results